Wegovy

Wegovy is specifically designed for weight loss and weight management in adults who are obese or overweight and have weight-related health issues such as hypertension, type 2 diabetes, or dyslipidemia. It uses semaglutide to mimic the action of an intestinal hormone that regulates appetite and calorie intake, leading to reduced hunger and significant weight loss.

Administered via weekly subcutaneous injections, Wegovy, in conjunction with lifestyle modifications like diet and exercise, has shown substantial efficacy in clinical trials, making it a promising option for individuals struggling with obesity.

Get in touch with us to learn more about it.